Will Eyemeye provide solution for Vision impairment and blindness?


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
The goal of EyeMyEye is to enhance one's quality of life by resolving vision issues with eyewear.

The leading causes of vision impairment and blindness are uncorrected refractive errors and cataracts.
The World Health Organization (WHO) estimates, that globally at least 2.2 billion people have a near or distance vision impairment. At least 1 billion or 80% of visual impairment is either preventable or curable with treatment. This includes cataracts, infections like river blindness and trachoma, glaucoma, diabetic retinopathy, uncorrected refractive errors, and some cases of childhood blindness.

Ganesh Iyer and Sudha Kalyan founded EyeMyEye, an online eyeglasses retailer, in 2021. It states that it has one million customers. In the eyewear market, it competes with companies such as Lenskart, Himalaya Opticals, MedPlusLens, Cool Winks, and Lens2Home, among others.

EyeMyEye, a one-year-old full-stack eyeglasses platform, has obtained Rs 39.35 crore that is $5 million in funding led by LC Nueva AIF, a joint venture between Lighthouse Canton, with offices in Singapore, and Nueva Capital, with headquarters in Delhi, among others.

According to the company’s regulatory filing with the Registrar of Companies (RoC), the board of directors approved a special resolution to allot 27,95,736 CCPS at the issue price of Rs 140.75 per share in order to raise the aforementioned amount. With an investment of Rs 18.65 crore, LC Nueva AIF led the round. Rajesh Bothra (Kobian Pte Ltd) and Lets Ventures each contributed Rs 2.75 crore and Rs 10 crore.


The Gurugram-based company is worth approximately Rs 142 crore, or $18 million (post-money). Its valuation at the time of the most recent investment was Rs 102 crore. In the past nine months, EyeMyEye has received the money in two rounds. The business acquired Rs 20.5 crore from angel investors and a number of high net-worth people in November as part of its pre-Series A round.


With funds in its kitty will Eyemyeye give tough competition to the existing giants like Lenskart, and Himalaya Opticals in the eyecare race?

Tags : #Eyemyeye #visionimparment #blindness #lenskart #healthcare #himalyaopticals #medicircle #smitakumar #medispeak

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

What Happens to Your Body During an All-Nighter?August 06, 2026
Childhood Obesity in India: A Growing Public Health Crisis That Demands Urgent AttentionAugust 06, 2026
Screen Time Effects on Children: What Every Indian Parent and Paediatrician Needs to KnowAugust 06, 2026
Kidney Transplant Recipient Defeats CancerAugust 05, 2026
Fermenta Biotech Lists on India’s National Stock ExchangeAugust 05, 2026
Asia Pacific leaders warn attacks against health and gender are undoing decades of progressAugust 05, 2026
Understanding Long-Term Impacts of Air Purification on ImmunityAugust 05, 2026
Understanding Epigenetics: How Lifestyle Changes Your DNAAugust 05, 2026
CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026